StayCon, a Colorado-based manufacturer of marijuana vape products, has voluntarily recalled 49 items after testing revealed contamination with methylene chloride, a chemical linked to cancer. The recall, issued to dispensaries last week, involves brands such as Maui Wowie and Grape Gorilla, some of which had been available on shelves for more than a year and a half. The action comes as state regulators face scrutiny for delaying the implementation of expanded testing protocols that would have detected the solvent earlier.
The contamination was identified by Bona Fides Laboratory in August during routine screening for pesticides and mold. Lab owner David Mathis stated that he notified both StayCon and the Colorado Marijuana Enforcement Division (MED) immediately upon detection, six weeks prior to the company’s voluntary recall notice. Methylene chloride is a solvent commonly used in paint strippers and has been targeted for bans in other consumer products due to health risks. The state has not yet issued a public consumer alert regarding the recall, a decision that has drawn criticism from industry observers and health advocates.
What the Right Is Saying
Industry representatives and some conservative commentators emphasize the voluntary nature of the recall and the complexities of regulatory implementation. StayCon, operating under the brand Craft, did not respond to requests for comment, but the company acted to remove products from the market before a forced state order. Supporters of the current regulatory approach argue that the state is balancing consumer safety with the economic viability of the cannabis industry, particularly for smaller manufacturers who might be burdened by overly stringent or rapidly changing compliance requirements.
Critics of immediate, heavy-handed regulation point to the recent legal challenges against the Environmental Protection Agency’s ban on methylene chloride. In a significant development, the U.S. Court of Appeals for the 5th Circuit struck down the EPA ban earlier this month, sending the matter back for further review. This legal uncertainty complicates state-level efforts to align with federal standards, as the chemical’s regulatory status remains in flux. Industry stakeholders argue that the state’s delay in implementation allowed time to navigate these legal shifts and ensure that new testing protocols are robust and enforceable.
What the Left Is Saying
Consumer advocates and public health experts argue that the delay in state oversight reflects a broader failure to protect consumers from toxic contaminants in the cannabis market. David Mathis, owner of Bona Fides Laboratory, criticized the state regulators for postponing the new testing rules, stating, “How many samples were not tested but have contaminants in them and were passed to the public?” Mathis noted that his lab was prepared to conduct the expanded screening since the start of July, when the rules were originally scheduled to take effect.
Progressive voices highlight the discrepancy between Colorado’s standards and those of other states, noting that 24 of the 43 states with regulated marijuana markets already require testing for methylene chloride and other solvents. Advocates argue that the state’s decision to back down from requiring independent lab sampling—after manufacturers cited cost concerns—allows companies to choose which labs test their products, potentially creating a conflict of interest that prioritizes profit over safety. The lack of a public state alert is viewed as a transparency issue, leaving consumers unaware of potential health risks associated with products they have already purchased.
What the Numbers Show
StayCon recalled 49 distinct products, including vape cartridges and other items sold under the Maui Wowie and Grape Gorilla brands. The contamination was detected by Bona Fides Laboratory in August, but the recall notice was not issued to dispensaries until last week, creating a six-week gap between detection and consumer notification. The state’s expanded testing rule, which covers methylene chloride and 30 other solvents, was originally scheduled to take effect in July but will now begin implementation at the end of September.
Colorado’s regulatory framework currently allows manufacturers to select the samples that labs test and the labs that perform the testing. This practice contrasts with recommendations made by regulators in January, who considered requiring lab personnel to collect samples to ensure impartiality. However, the state backed away from this proposal after top manufacturers argued that independent sampling would be too expensive. According to the Marijuana Enforcement Division, the state public health department requested additional time to review and certify labs for the new testing capabilities.
The Bottom Line
The recall underscores the ongoing tension between regulatory speed and industry flexibility in Colorado’s mature cannabis market. While StayCon’s voluntary action removes contaminated products from shelves, the delay in state alerts and the continued reliance on manufacturer-selected testing samples leave questions about consumer awareness and product integrity. With the new testing protocols set to begin implementation at the end of the month, regulators face pressure to ensure that future contaminants are detected and communicated to the public more swiftly. Consumers are advised to check for recalls on specific vape brands and monitor state health department updates for further guidance.